tyc7111cc太阳成集团

洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
医药数据查询

【ChiCTR2100050580】Early detection and surveillance of COVID-19 infection by non-invasive ophthalmic evaluations

基本信息
登记号

ChiCTR2100050580

试验状态

正在进行

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2021-08-29

临床申请受理号

/

靶点

/

适应症

新型冠状病毒肺炎(COVID-19)

试验通俗题目

Early detection and surveillance of COVID-19 infection by non-invasive ophthalmic evaluations

试验专业题目

Early detection and surveillance of COVID-19 infection by non-invasive ophthalmic evaluations

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

1. To compare among groups on - viral load in ocular versus upper respiratory samples; - recent-onset ocular versus respiratory symptoms - COVID19-associated ocular changes 2. To follow-up on subjects with any positive ocular finding(s) up to 12 months

试验分类
试验类型

连续入组

试验分期

其它

随机化

N/A

盲法

N/A

试验项目经费来源

Food and Health Bureau - Health and Medical Research Fund Commissioned Research on the Novel Coronavirus Disease (COVID-19)

试验范围

/

目标入组人数

2080

实际入组人数

/

第一例入组时间

2021-09-01

试验终止时间

2023-08-09

是否属于一致性

/

入选标准

1. Confirmed cases fulfilling laboratory criteria; 2. Probable cases: epidemiological link to a confirmed case/outbreak of COVID-19 and radiological evidence of pneumonia regardless of COVID-19 testing results; 3. Convalescent cases; 4. Subjects with epidemiological link to COVID-19, who meet the CHP reporting criteria of COVID-19, inbound travellers under compulsory quarantine at designated places.；

排除标准

1. Mentally not fit for consent; 2. Patients with recent (< 6 months) pneumonia or COVID19 cannot be recruited as healthy control.；

研究者信息
研究负责人姓名
试验机构

Food and Health Bureau - Health and Medical Research Fund

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址

最新临床资讯

tyc7111cc太阳成集团企业版
50亿+条医药数据随时查
7天免费试用
体验产品

同适应症药物临床试验

更多